After obtaining a favorable suggestion from the EMA in 2024, the United States biotech business has actually had its applicatoin declined by the FDA.
发布者:Dr.Durant,转转请注明出处:https://robotalks.cn/outlook-therapeutics-plunges-after-rejection-from-the-fda-2/